30 Technology Holds Inaugural Scientific Advisory Board Meeting

We are delighted to announce the first meeting of 30 Technology’s newly formed Scientific Advisory Board (SAB) held in our offices in Central London.

30 Technology launches a critical clinical trial in patients with newly diagnosed tuberculosis

We are delighted to announce that our latest clinical trial ‘RESP30X-EBA’ is active and recruiting at the TASK Clinical Research Centre, South Africa.

30 Technology expands its clinical team

30 Technology has been actively engaged in expanding its clinical team to drive its lead respiratory assets through multiple ongoing early phase clinical trials.

30 TECHNOLOGY: REALISING THE FULL POTENTIAL OF THERAPEUTIC NITRIC OXIDE

30 TECHNOLOGY is developing nitric oxide-generating technologies
for a range of health care applications

Watch video